BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6321127)

  • 1. [Serologic diagnosis of cytomegalic inclusion disease using the Elisa technic in kidney transplant patients].
    Dennin RH; Herhan J; Schulz E; Sack K
    Dtsch Med Wochenschr; 1984 Feb; 109(6):214-6. PubMed ID: 6321127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections.
    Baldwin WM; van Es A; Valentijn RM; van Gemert GW; Daha MR; Vanes LA
    Clin Exp Immunol; 1982 Dec; 50(3):515-24. PubMed ID: 6299633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.
    Just-Nübling G; Korn S; Ludwig B; Stephan C; Doerr HW; Preiser W
    Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
    Kraat YJ; Stals FS; Christiaans MH; Lazzarotto T; Landini MP; Bruggeman CA
    J Med Virol; 1996 Mar; 48(3):289-94. PubMed ID: 8801292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific IgM of cytomegaloviruses and primary infection in kidney transplant patients].
    Devillechabrolle A; Nguyen TT; Luciani J; Frantz P; Huraux JM
    Pathol Biol (Paris); 1987 Oct; 35(8):1123-6. PubMed ID: 2825100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus antibodies in renal transplant recipients.
    Jankowski M; Gut W; Nawrocka E; Gradowska L; Roncewicz Z; Rowińska D
    Acta Microbiol Pol; 1982; 31(3-4):279-85. PubMed ID: 6189377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complications of infections attributed to cytomegalovirus in a group of 52 kidney transplant patients].
    Galezowski N; Godeaut E; Berche P; Bonissol C; Debure A; Kreis H
    Ann Med Interne (Paris); 1987; 138(5):369-71. PubMed ID: 2823666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients].
    Eichler C; Kaden J; May G
    Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serologic diagnosis of primary cytomegalovirus infections in patients following kidney transplantation using the indirect immunofluorescence technic and the complement-fixation test].
    Eichler C; Kaden J; Adamczyk G; Gärtner L
    Z Urol Nephrol; 1985 Aug; 78(8):447-50. PubMed ID: 3002072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between the symptomatic cytomegalovirus infection and the fluctuation of anti-CMV antibodies in patient after renal transplantation].
    Miyamoto N; Takamura Y
    Rinsho Byori; 1992 Feb; 40(2):189-93. PubMed ID: 1316499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantation.
    Schmidt CA; Oettle H; Peng R; Neuhaus P; Blumhardt G; Lohmann R; Wilborn F; Osthoff K; Oertel J; Timm H
    Transplantation; 1995 Apr; 59(8):1133-8. PubMed ID: 7732559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients.
    Naumnik B; Małyszko J; Chyczewski L; Kovalchuk O; Małyszko J; Myśliwiec M
    Transplant Proc; 2007 Nov; 39(9):2748-50. PubMed ID: 18021976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of CMV in amniotic fluid and cervicovaginal smear samples by real-time PCR assay in prenatal diagnosis.
    Biri A; Bozdayi G; Ciçfti B; Dinç B; Yücel A; Rota S
    Arch Gynecol Obstet; 2006 Feb; 273(5):261-6. PubMed ID: 16001197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late onset of fatal cytomegalovirus infection after renal transplantation. Primary or reactivation infection?
    Linnemann CC; Dunn CR; First MR; Alvira M; Schiff GM
    Arch Intern Med; 1978 Aug; 138(8):1247-50. PubMed ID: 209756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of cytomegalovirus infection in recipients of renal transplantation].
    Fan J; Qian J; He Q; Ma WH; Chen JH; Zhou L; Cai T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Sep; 15(3):262-4. PubMed ID: 11986702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid detection of IgG and IgM antibodies for cytomegalovirus by the enzyme linked immunosorbent assay (ELISA).
    Cappel R; de Cuyper F; de Braekeleer J
    Arch Virol; 1978; 58(3):253-8. PubMed ID: 215109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic markers of the risk of cytomegalovirus infection among immunosuppressed patients].
    Tardy JC; Bosshard S; Aymard M
    Rev Epidemiol Sante Publique; 1985; 33(4-5):297-303. PubMed ID: 3006185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sero-molecular evaluation of human cytomegalovirus disease in renal transplant rejection.
    Kishore J; Mukhopadhyay C; Savitri ; Ayyagari A; Sharma RK
    Nepal Med Coll J; 2004 Dec; 6(2):83-7. PubMed ID: 16295735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Demonstration of cytomegalovirus (CMV) IgG and IgM in homosexuals and transsexuals using ELISA].
    Kiyan M; Cengiz AT; Kendi O; Tümer AR; Bilge Y; Uğurel MS
    Mikrobiyol Bul; 1993 Apr; 27(2):119-26. PubMed ID: 8388984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
    Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
    Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.